Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression<b>:</b>A randomized, double‐blind, placebo‐controlled trialEugene R. Viscusi, Sukirti Bagal, Marc C. Torjman et al.|Clinical and Translational Science|2021Cited by 34
Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug usersMegan J. Shram, Frédérique Menzaghi, Michael E. Lewis et al.|Clinical and Translational Science|2021Cited by 32